DWP213388

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DWP213388, covering 2024-11-05 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects [Phase 1]

See pricing